Balance Sheet Data

CytRx Corporation (CYTR)

$ 3.22
0.38 (+13.38%)

Year
A/P
2013
Actual
2014
Actual
2015
Actual
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Total Cash 38.5777.8457.3056.9637.6421.3716.1310170.19226.92302.56403.41537.88
Total Cash (%)
Account Receivables 0.132.124.620.187.530.150.010.3310.7714.3619.1525.5434.05
Account Receivables (%)
Inventories -------------
Inventories (%)
Accounts Payable 3.856.668.066.414.121.230.891.4018.0724.1032.1342.8457.12
Accounts Payable (%)
Capital Expenditure -0.04-0.96-0.33-1.02-0.13-0.01-0.02-0.03-1.45-1.94-2.59-3.45-4.60
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.